Silibinin mode(s) of action against hepatitis C virus: A controversy yet to be resolved


  • Potential conflict of interest: Nothing to report.

    This correspondence first published online ahead of print on 27 Jun 2011, and has since been updated for print. The title has been revised.

  • This work was performed under the auspices of the U.S. Department of Energy under contract DE-AC52-06NA25396, and supported by National Institutes of Health grants RR06555-19, P20-RR018754-6, AI065256-5, R56-AI078881-01, and AI28433-20, the National Science Foundation under grant NSF PHY05-51164, and by the University of Illinois Walter Payton Liver Center GUILD.

No abstract is available for this article.